Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression

The United States lung cancer epidemic has not yet been controlled by present prevention and treatment strategies. Overexpression of a Mr 31,000 protein, heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1, had shown promise as a marker of lung cancer. In a pilot study of archived preneoplastic sp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cancer research 1997-12, Vol.3 (12), p.2237-2246
Hauptverfasser:	TOCKMAN, M. S, MULSHINE, J. L, YAO, S.-X, PIANTADOSI, S, EROZAN, Y. S, GUPTA, P. K, RUCKDESCHEL, J. C, TAYLOR, P. R, ZHUKOV, T, ZHOU, W.-H, QIAO, Y.-L
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Carcinoma, Non-Small-Cell Lung - epidemiology Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - surgery China DNA-Binding Proteins - analysis DNA-Binding Proteins - genetics Female Gene Expression Regulation, Neoplastic Heterogeneous-Nuclear Ribonucleoprotein Group A-B Humans Immunohistochemistry Lung Neoplasms - epidemiology Lung Neoplasms - genetics Lung Neoplasms - pathology Lung Neoplasms - surgery Male Medical sciences Middle Aged Mining Occupational Exposure Pneumology Precancerous Conditions - genetics Precancerous Conditions - pathology Prognosis Prospective Studies Reproducibility of Results Risk Factors Smoking Sputum - chemistry Tin Treatment Outcome Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!